Cosmos Holdings

Cosmos Health, Inc. is a pharmaceutical company, which engages in the importation, exportation, distribution, and sale of pharmaceutical products. It is also involved in the research and development of its business units, and acquisition of pharmaceutical companies. The firm offers over-the-counter drugs, branded and generic medicines, and dietary and vitamin supplements. The company was founded on July 21, 2009 and is headquartered in Chicago, IL.

Earnings data Q4 2023

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Cosmos Health, Inc. is a pharmaceutical company, which engages in the importation, exportation, distribution, and sale of pharmaceutical products. It is also involved in the research and development of its business units, and acquisition of pharmaceutical companies. The firm offers over-the-counter drugs, branded and generic medicines, and dietary and vitamin supplements. The company was founded on July 21, 2009 and is headquartered in Thessaloniki, Greece.

Ambev

Rigel Pharmaceuticals

Use these tips for trading penny stocks right now The post Don't Invest in Penny Stocks Until You've Read This Article appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Don't Invest in Penny Stocks Until You've Read This Article

CHICAGO, IL / ACCESSWIRE / December 2, 2022 / Cosmos Holdings d/b/a Cosmos Health, Inc. ("the Company") (Nasdaq:COSM) , a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, provided a summary regarding recent share activity, including the participation of CEO, Greg Siokas on all capital raises. Management reiterates its belief in the financial strength of Cosmos Health, and its commitment to the growth and profitability of the Company.

Cosmos Health Provides a Summary Regarding Recent Share Activity and Reiterates its Belief and Commitment to the Financial Strength and the Growth and Profitability of the Company

Cosmos Holdings stock is up 618% in November likely due to a short squeeze. This article explains why Cosmos Holdings may still be a good long-term investment

Cosmos Holdings May be a Long-Term Buy with Short-Term Risk

CHICAGO, IL / ACCESSWIRE / November 29, 2022 / Cosmos Holdings d/b/a Cosmos Health, Inc. ("the Company") (NASDAQ:COSM) , a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, today announced that it has entered the development phase for CCX0722, an innovative product for obesity and weight management, based on the effectiveness of biocompatible 3D spatial fillers, from natural ingredients. Spatial fillers are hydrophilic biopolymer grids capable of absorbing and retaining large amounts of water or biological fluids.

Cosmos Health Enters the Development Phase for CCX0722, an Innovative Product for Obesity and Weight Management

Shares of Cosmos (NASDAQ: COSM ) are up by more than 700% this month. Investors have attributed this astounding price action in COSM stock to a short squeeze, as the company has not released any news to cause gains this significant.

5 Investors Betting Big on Cosmos (COSM) Stock

ComSovereign Holding

Taboola

This is why trading penny stocks in 2022 is fundamentally different The post Why Buying Penny Stocks in 2022 is Unlike Any Other Time appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Why Buying Penny Stocks in 2022 is Unlike Any Other Time

Helbiz

 Nuwellis

Use these tips for buying penny stocks right now The post Buying Penny Stocks as 2022 Ends? 3 Tips and Tricks  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Buying Penny Stocks as 2022 Ends? 3 Tips and Tricks

Cosmos Holdings (NASDAQ: COSM ) stock is ripping higher on Wednesday, currently up more than 20% so far today. At today's high, though, COSM stock was up more than 100%.

Is a Giant Short Squeeze Brewing in Cosmos (COSM) Stock?

Palisade Bio

Check out these tips for trading penny stocks The post Should You Be Buying Penny Stocks? Here's 3 Reasons Why appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Should You Be Buying Penny Stocks? Here's 3 Reasons Why

Siyata Mobile Inc.

Wish

How to trade under $1 penny stocks The post Buying Penny Stocks Under $1? What You Need to Know  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Buying Penny Stocks Under $1? What You Need to Know

CHICAGO, IL / ACCESSWIRE / November 21, 2022 / Cosmos Holdings d/b/a Cosmos Health, Inc. ("the Company") (Nasdaq:COSM) , a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, today announced that its Sky Premium Life luxury food supplement brand will be sold on Ronda, the official inflight magazine of the airline company Iberia of BRITISH AIRWAYS group. Ronda is available free of charge to the over 10 million passengers who fly Iberian Airlines annually.

Cosmos Health to Sell its Sky Premium Life Luxury Food Supplement Brand on Iberian Airlines' In-flight Magazine, Ronda.

Ardelyx

This is what penny stocks need to succeed in 2022 The post What Do Penny Stocks Need to Succeed in 2022?  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

What Do Penny Stocks Need to Succeed in 2022?

Compugen

GoHealth, Inc.

Volta

Penny stocks under $1 to watch before next week. The post 4 Cheap Penny Stocks To Buy For Under $1 Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

4 Cheap Penny Stocks To Buy For Under $1 Right Now

Stock will continue to trade on Nasdaq beyond November 21, 2022 CHICAGO, IL / ACCESSWIRE / November 17, 2022 / Cosmos Holdings d/b/a Cosmos Health, Inc. ("the Company") (NASDAQ:COSM) , a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, today announced that on November 10, 2022, Cosmos Holdings received a non-compliance letter from the Nasdaq Stock Market for its failure to maintain a minimum closing bid price of $0.10 per share for ten (10) consecutive business days in accordance with Nasdaq Listing Rule 5810(c)(3)(A)(ii). Pursuant to a prior non-compliance letter from Nasdaq dated July 26, 2022, the Company had until January 23, 2023, to regain compliance by the closing bid price of the Company's common stock being at least $1.00 per share for ten (10) consecutive trading days.

Cosmos Health Requests Appeal from the Nasdaq Stock Market

CHICAGO, IL / ACCESSWIRE / November 15, 2022 / Cosmos Holdings (d/b/a Cosmos Health, Inc. ) ("the Company") (Nasdaq:COSM) , a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, today provided a business update and reported financial results for the third quarter and nine months ended September 30, 2022. Third Quarter 2022 Financial Highlights Revenues were $12.0M versus $13.6M in 3Q21.

Cosmos Health Reports Third Quarter 2022 Financial Results

Freight Technologies Inc

Exela Technologies

Are you trading penny stocks with these tips? The post Don't Invest in Penny Stocks Until You've Learned These Tips appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Don't Invest in Penny Stocks Until You've Learned These Tips

Yamana Gold

Trading tips for penny stocks as 2022 comes to an end The post End of Year Penny Stocks Trading Recommendations  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

End of Year Penny Stocks Trading Recommendations

Fast Radius

Opendoor

Use these penny stocks trading strategies The post Advanced Penny Stocks Trading Strategies to Consider  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Advanced Penny Stocks Trading Strategies to Consider

ESSA Pharma

RLX Technology

SINTX Technologies Inc

Use these strategies for making money with penny stocks The post Top Strategies for Making Money With Penny Stocks appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Top Strategies for Making Money With Penny Stocks

Black Diamond Therapeutics

IMARA

Local Bounti Corp

Penny stock picks from Insiders in October 2022. The post 4 Penny Stocks To Buy: Insider Picks For October appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

4 Penny Stocks To Buy: Insider Picks For October

Adamis Pharmaceuticals

AnPac Bio-Medical Science Co

Borqs Technologies

Clever Leaves Holdings

Corbus Pharmaceuticals Holdings

Altamira Therapeutics Ltd

Matinas BioPharma Hlds

Nutex Health Inc

Oblong

Penny stocks to watch under $1 right now. The post 10 Top Penny Stocks To Buy For Uner $1 Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

10 Top Penny Stocks To Buy For Uner $1 Right Now

Penny stocks to watch under $1 right now. The post Good Penny Stocks To Buy Now?

Good Penny Stocks To Buy Now? 7 Under $1 To Watch This Week

CHICAGO, IL / ACCESSWIRE / October 18, 2022 / Cosmos Holdings (d/b/a Cosmos Health, Inc.) ("Cosmos" or the "Company") (NASDAQ:COSM), a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, today announced the pricing of its "reasonable best efforts" public offering of 62,500,000 shares of common stock (or common stock equivalents), Series A Warrants to purchase 62,500,000 shares of common stock and Series B Warrant to purchase 62,500,000 shares of common stock at a combined price of $0.12 per share and warrant for aggregate gross proceeds of $7.5 million, before deducting placement agent fees and other offering expenses. The offering includes participation from Grigorios Siokas, CEO of Cosmos Holdings, Inc. as well as various Company advisors.

Cosmos Health Announces Pricing of $7.5 Million Upsized Public Offering

Provides Additional Financial Flexibility in Exchange for New Warrants CHICAGO, IL / ACCESSWIRE / October 4, 2022 / Cosmos Holdings d/b/a Cosmos Health, Inc. ("Cosmos") (NASDAQ:COSM) , a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, today announced that it has entered into an agreement to replace its previously structured warrants with new vanilla warrants. The existing holders of Warrants issued as of February 28, 2022 will purchase an aggregate of 21,238,254 shares of Common Stock.

Cosmos Health Enters into a Warrant Exchange Agreement, Replacing Structured Warrants with Plain-Vanilla Warrants

CHICAGO, IL / ACCESSWIRE / September 22, 2022 / Cosmos Holdings d/b/a Cosmos Health, Inc. ("Cosmos") (NASDAQ:COSM) , a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, today announced that it has entered into an agreement with Virax Biolabs (VRAX), to become the distributor of Monkeypox Virus Real-Time PCR Detection Kits. Cosmos will have exclusive distribution rights for Greece and Cyprus, with the opportunity to distribute the test kits across Europe on a non-exclusive basis.

News for Cosmos Holdings Stock (COSM)